1. Home
  2. VFS vs KYMR Comparison

VFS vs KYMR Comparison

Compare VFS & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VinFast Auto Ltd.

VFS

VinFast Auto Ltd.

HOLD

Current Price

$4.29

Market Cap

6.7B

Sector

Finance

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$84.33

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFS
KYMR
Founded
2017
2015
Country
Vietnam
United States
Employees
17823
N/A
Industry
Blank Checks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VFS
KYMR
Price
$4.29
$84.33
Analyst Decision
Buy
Strong Buy
Analyst Count
4
26
Target Price
$5.83
$107.72
AVG Volume (30 Days)
926.8K
440.9K
Earning Date
06-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,211,000.00
Revenue This Year
$70.58
$10.61
Revenue Next Year
N/A
$8.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.78
$28.06
52 Week High
$5.29
$103.00

Technical Indicators

Market Signals
Indicator
VFS
KYMR
Relative Strength Index (RSI) 56.52 49.62
Support Level $3.16 $77.71
Resistance Level $4.88 $90.15
Average True Range (ATR) 0.25 3.86
MACD -0.05 -0.30
Stochastic Oscillator 20.62 52.87

Price Performance

Historical Comparison
VFS
KYMR

About VFS VinFast Auto Ltd.

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: